Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

May 2023

Aiosyn, Radboud University Medical Center, And Pathologie-DNA Are Awarded a EUR 1.300.000 EFRO Grant To Develop AI-powered Solutions For Cancer Diagnostics

2023-05-09T13:38:51+00:00

Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to accelerate the development of AI technology for breast and skin cancer diagnostics. With the AIRAT project, the three organizations will join forces to introduce CE-marked deep learning algorithms for automated mitosis detection to the market.

Aiosyn, Radboud University Medical Center, And Pathologie-DNA Are Awarded a EUR 1.300.000 EFRO Grant To Develop AI-powered Solutions For Cancer Diagnostics2023-05-09T13:38:51+00:00

Immuno-oncology 101 With Elfirede Nößner, HelmholzZentrum, Visiopharm Advisor

2025-05-06T13:04:46+00:00

Today’s podcast guest, Prof. Elfriede Noessner will walk us through the complexities of the immune system, explain how it is being influenced to cure cancer and what role tissue image analysis plays in immuno-oncology.

Immuno-oncology 101 With Elfirede Nößner, HelmholzZentrum, Visiopharm Advisor2025-05-06T13:04:46+00:00

Aiosyn’s AI-powered Quality Control For Digital Pathology Slides Is Now Available In Sectra Amplifier Marketplace

2023-05-03T18:55:39+00:00

Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace. Through the Sectra platform, pathology laboratories can now easily access and integrate AiosynQC into their workflow.

Aiosyn’s AI-powered Quality Control For Digital Pathology Slides Is Now Available In Sectra Amplifier Marketplace2023-05-03T18:55:39+00:00

Novel Digital Pathology Pipeline May Reduce Costs of Circulating Tumor Cell Characterization

2023-05-03T08:40:08+00:00

In a recent proof-of-concept study, Trinity College Dublin researchers at Coombe Women’s and Infants University Hospital and St. James’s Hospital, Dublin, Ireland, developed and tested a low-cost CTC isolation and characterization pipeline based on digital pathology methods.1

Novel Digital Pathology Pipeline May Reduce Costs of Circulating Tumor Cell Characterization2023-05-03T08:40:08+00:00

April 2023

Aiforia Has Received A Funding Decision From Business Finland To Accelerate The Development Of AI-assisted Software Solutions For Clinical Pathology And Drug Development

2023-04-27T15:01:23+00:00

Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.

Aiforia Has Received A Funding Decision From Business Finland To Accelerate The Development Of AI-assisted Software Solutions For Clinical Pathology And Drug Development2023-04-27T15:01:23+00:00

Survey Of Liver Pathologists To Assess Attitudes Towards Digital Pathology And Artificial Intelligence

2023-04-27T11:45:42+00:00

A survey of members of the UK Liver Pathology Group (UKLPG) was conducted, comprising consultant histopathologists from across the UK who report liver specimens and participate in the UK National Liver Pathology External Quality Assurance scheme. The aim of this study was to understand attitudes and priorities of liver pathologists towards digital pathology and artificial intelligence (AI).

Survey Of Liver Pathologists To Assess Attitudes Towards Digital Pathology And Artificial Intelligence2023-04-27T11:45:42+00:00

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

2023-04-26T08:38:48+00:00

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs' HALO AP® image management software platform and Lunit's suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows2023-04-26T08:38:48+00:00

Spatial Biology Analysis Reveals B Cell Follicles In Secondary Lymphoid Structures May Regulate Anti-tumor Responses At Initial Melanoma Diagnosis

2023-04-21T09:58:44+00:00

At the time of initial melanoma diagnosis, the analysis of spatial biology reveals that B cell follicles in secondary lymphoid structures may have a role in regulating anti-tumor responses.

Spatial Biology Analysis Reveals B Cell Follicles In Secondary Lymphoid Structures May Regulate Anti-tumor Responses At Initial Melanoma Diagnosis2023-04-21T09:58:44+00:00
Go to Top